HI
BEAM icon

Hudock Inc’s Beam Therapeutics BEAM Stock Holding History

Hudock Inc’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-500
Closed -$23K – 199
2022
Q3 		$23K Hold
500
– – 0.01% 412
2022
Q2 		$19K Hold
500
– – 0.01% 425
2022
Q1 		$28K Hold
500
– – 0.01% 393
2021
Q4 		$39K Hold
500
– – 0.01% 353
2021
Q3 		$43K Hold
500
– – 0.01% 341
2021
Q2 		$64K Hold
500
– – 0.02% 291
2021
Q1 		$40K Hold
500
– – 0.01% 345
2020
Q4 		$40K Hold
500
– – 0.01% 325
2020
Q3 		$12K Hold
500
– – ﹤0.01% 431
2020
Q2 		$14K Hold
500
– – 0.01% 408
2020
Q1 		$9K Buy
+500
New +$10.9K ﹤0.01% 408

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Hudock Inc's BEAM Position: Q4 2022 in Review

Hudock Inc sold out of Beam Therapeutics (BEAM) in Q4 2022, closing a stake of 500 shares — an estimated $23K sold.

Hudock Inc first reported a position in BEAM in Q1 2020 and held it in 11 quarters. The position peaked at $64K in Q2 2021. 207 funds tracked by Wall St. Rank hold BEAM as of Q4 2022.

  • Hudock Inc reported no remaining Beam Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Hudock Inc sold 500 Beam Therapeutics shares in Q4 2022, an estimated $23K.
  • Hudock Inc first reported a position in Beam Therapeutics in Q1 2020 and held it in 11 quarters.
  • Hudock Inc's Beam Therapeutics position peaked at $64K in Q2 2021.
  • 207 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2022.

Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.